- Home
- CSW vs CRNX Comparison
CSW vs CRNX Comparison
Compare CSW & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSW | CRNX |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.1B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | CSW | CRNX |
|---|---|---|
| Price | $302.91 | $47.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $292.50 | $71.00 |
| AVG Volume (30 Days) | 176.3K | ★ 1.4M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | ★ 15.78 | N/A |
| EPS | ★ 8.52 | N/A |
| Revenue | ★ $964,795,000.00 | $1,535,000.00 |
| Revenue This Year | $22.62 | $425.31 |
| Revenue Next Year | $12.16 | $943.50 |
| P/E Ratio | $35.69 | ★ N/A |
| Revenue Growth | 14.87 | ★ 47.74 |
| 52 Week Low | $230.45 | $24.10 |
| 52 Week High | $419.27 | $60.34 |
Technical Indicators
Market Signals| Indicator | CSW | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 77.79 | 61.29 |
| Support Level | $267.14 | $44.52 |
| Resistance Level | $273.81 | $48.62 |
| Average True Range (ATR) | 9.18 | 2.00 |
| MACD | 5.47 | 0.29 |
| Stochastic Oscillator | 99.52 | 72.38 |
Price Performance
Historical ComparisonAbout CSW CSW Industrials Inc. Common Stock
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.